Humboldt Fund
VC · New York · United States
Stages
Investment region
Industries
Profile
Humboldt Fund is a venture capital firm based in New York, founded in 2020. The firm is led by a team of four professionals, including General Partner Sebastian Bernales, a former VP of Discovery Biology at Medivation. Humboldt Fund is distinguished by its focus on building globally distributed biotech models and fostering US-Latin America scientific ties. The firm invests in a diverse range of sectors including biotechnology, food, healthcare, materials, energy, and molecular biology. Humboldt Fund typically invests in Series A rounds, with check sizes ranging from $100k to $5m. Their investments are primarily focused in the United States, and they have a portfolio of 32 companies. Notable funds include co-investments with partners like SOSV. Humboldt Fund's portfolio includes notable companies such as Momentum Therapeutics - biotechnology, Spiral Therapeutics - drug discovery, Metagenomi Therapeutics - drug discovery, Concerto Biosciences - biotechnology, and Finless Foods - food products. The firm has seen successful exits including IPOs and acquisitions, with companies like Finch Therapeutics and MycoWorks.
Contacts (2)
| Name | Title | Phone | ||
|---|---|---|---|---|
| General Partner | — | — | — | |
| — | — | — | — |
Name, email and phone are partially hidden. Subscribe to see them in full.